Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by mingzhuon Sep 24, 2016 3:15pm
280 Views
Post# 25273916

My take on CXR part 2

My take on CXR part 21,The biggest positive for CXR is to launch 60 drugs bt the end of 2018, 2 per month on average.
2, short squeeze. CXR has 27% of float short interest, ranked 40th highest short in US

Shorts As A Percentage of Float
Monday, September 12, 2016
Companies where shares shorted represent the largest percentage of float.
Company Symbol 8/31/16 8/15/16 Chg % Chg % Float Days to
cover
Avg daily
volume
1 Insys Therapeutics, Inc. INSY 16,474,780 15,808,292 666,488 4.2 69.0 21 803,562
2 Cal-Maine Foods, Inc. CALM 13,346,218 13,591,164 -244,946 -1.8 45.7 24 550,856
3 JAKKS Pacific, Inc. JAKK 5,781,272 5,902,009 -120,737 -2.1 43.7 39 149,591
4 Altisource Portfolio Solutions S.A. ASPS 5,223,459 5,142,901 80,558 1.6 43.4 15 359,705
5 BofI Holding, Inc. BOFI 23,375,947 23,038,062 337,885 1.5 42.0 14 1,685,496
6 Natural Health Trends Corp. - Commn Stock NHTC 2,900,569 3,004,642 -104,073 -3.5 40.1 36 80,055
7 Freshpet, Inc. FRPT 7,137,273 7,523,519 -386,246 -5.1 39.2 57 125,992
8 Eagle Pharmaceuticals, Inc. EGRX 3,656,419 3,714,118 -57,699 -1.6 39.0 9 422,156
9 Gogo Inc. GOGO 21,973,474 18,994,680 2,978,794 15.7 38.7 24 910,387
10 TOP Ships Inc. TOPS 336,015 345,027 -9,012 -2.6 37.7 0 750,768
11 LendingTree, Inc. TREE 2,473,628 2,716,139 -242,511 -8.9 34.7 7 377,986
12 Sarepta Therapeutics, Inc. SRPT 14,795,498 16,204,551 -1,409,053 -8.7 33.4 8 1,791,054
13 ZIOPHARM Oncology Inc ZIOP 38,909,971 39,044,106 -134,135 -0.3 33.0 23 1,661,130
14 Power Solutions International, Inc. PSIX 1,558,827 1,511,599 47,228 3.1 33.0 16 97,787
15 GoPro, Inc. - Class A Common Stock GPRO 30,848,133 30,539,623 308,510 1.0 33.0 5 5,671,794
16 Air Methods Corporation AIRM 11,407,903 11,542,671 -134,768 -1.2 32.8 40 285,799
17 Ubiquiti Networks, Inc. UBNT 7,789,709 8,099,907 -310,198 -3.8 31.8 25 311,372
18 Ebix, Inc. EBIX 6,698,840 6,218,804 480,036 7.7 31.5 36 188,651
19 SolarEdge Technologies, Inc. SEDG 7,776,882 7,654,269 122,613 1.6 31.5 14 549,936
20 Spark Energy, Inc. - Class A Common Stock SPKE 1,945,150 1,905,803 39,347 2.1 31.1 8 241,548
21 Encore Capital Group Inc ECPG 7,730,017 7,812,702 -82,685 -1.1 31.0 43 179,790
22 Egalet Corporation EGLT 3,618,284 2,781,243 837,041 30.1 30.5 17 208,556
23 Heron Therapeutics, Inc. HRTX 11,716,151 11,110,892 605,259 5.5 30.3 21 569,943
24 Conn's, Inc. CONN 6,474,739 6,224,011 250,728 4.0 30.1 15 432,796
25 MannKind Corporation MNKD 95,640,324 87,818,722 7,821,602 8.9 29.7 20 4,864,196
26 Clovis Oncology, Inc. CLVS 9,810,111 8,692,848 1,117,263 12.9 29.6 2 4,294,081
27 Ocean Rig UDW Inc. ORIG 12,404,024 14,077,029 -1,673,005 -11.9 29.4 4 3,494,073
28 Marriott International - Class A Common Stock MAR 57,252,281 56,967,494 284,787 0.5 29.4 25 2,283,979
29 Innoviva, Inc. INVA 22,403,118 23,221,460 -818,342 -3.5 28.9 40 561,890
30 SolarCity Corporation SCTY 18,662,686 19,915,394 -1,252,708 -6.3 28.4 11 1,764,088
31 Pilgrim's Pride Corporation PPC 16,663,910 17,755,261 -1,091,351 -6.2 28.4 15 1,149,143
32 Nexstar Broadcasting Group, Inc. - Class A Common Stock NXST 8,324,181 8,077,964 246,217 3.1 28.2 30 281,075
33 LGI Homes, Inc. LGIH 4,586,986 4,806,921 -219,935 -4.6 27.2 10 449,848
34 ZELTIQ Aesthetics, Inc. ZLTQ 9,611,259 10,314,128 -702,869 -6.8 27.2 18 531,875
35 Approach Resources Inc. AREX 9,840,624 9,317,135 523,489 5.6 27.0 5 1,826,945
36 Advaxis, Inc. ADXS 9,307,127 9,718,568 -411,441 -4.2 26.5 9 1,041,214
37 Foundation Medicine, Inc. FMI 3,390,176 3,597,437 -207,261 -5.8 26.4 20 167,964
38 SunPower Corporation SPWR 15,446,622 16,707,466 -1,260,844 -7.6 26.4 6 2,510,287
39 Immunomedics, Inc. IMMU 23,483,869 23,793,619 -309,750 -1.3 26.3 26 913,623
40 Concordia International Corp. - Common Shares CXRX 10,767,065 12,590,739 -1,823,674 -14.5 26.3 9 1,134,231
41 Credit Acceptance Corporation CACC 2,665,840 2,625,184 40,656 1.6 26.2 13 208,080
42 Lands' End, Inc. LE 5,201,174 5,321,856 -120,682 -2.3 26.2 29 181,984
43 Kona Grill, Inc. KONA 2,361,244 2,567,438 -206,194 -8.0 25.9 29 81,939
44 XBiotech Inc. XBIT 3,745,738 3,765,092 -19,354 -0.5 25.9 25 148,997
45 Aduro Biotech, Inc. ADRO 6,415,762 6,146,893 268,869 4.4 25.9 19 343,166
46 magicJack VocalTec Ltd - Ordinary Shares CALL 2,687,631 2,666,048 21,583 0.8 25.8 18 148,922
47 Renewable Energy Group, Inc. REGI 9,488,148 9,526,147 -37,999 -0.4 25.3 23 407,172
48 Hibbett Sports, Inc. HIBB 5,580,078 5,519,983 60,095 1.1 25.2 10 567,448
49 Reata Pharmaceuticals, Inc. - Class A Common Stock RETA 1,212,610 831,661 380,949 45.8 25.1 15 83,583
50 Stamps.com Inc. STMP 3,951,306 4,460,492 -509,186 -11.4 25.0 9 450,002
Sources: FactSet Research Systems; WSJ Market Data Group

If there is slight change of sentiment, we will see short squeeze quickly and push SP sky high.. CXR is highly leveraged. As some anaylist points out 25% change of PE ratio, CXR can be $1 or $22 . I am on the $22 side.

3, There is no reason to believe qtr 3 fiancials will be much different from qtr2. or may be slight down of revenue in North America since a generic cpmpetitive drug of another company was launched in july.

If there is no more big negative coming out, $5 is the bottom. We will see gradual recovery in next 2 months till qt3 financials come out.

There are so many negative posts on this board, a sure sigh of price bottoming.
<< Previous
Bullboard Posts
Next >>